JPM 2023: Novocure Announces Trial Results; ResMed Expands Manufacturing; Abbott's IVD Bet Pays Off
Also: Thermo Fisher Projects Steady Growth, Labcorp Absorbs Acension; GE HealthCare Debuts As Standalone Company
Executive Summary
The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies; Some use the conference as a platform for major announcements while some just take the opportunity to explain their 2023 outlook to investors. Here are some of the highlights from the presentations on the second day of the meeting.
You may also be interested in...
GE HealthCare Stretches To The Next Level
GE HealthCare added a new chapter to the 130-year history of GE Corp when it spun off from the group on 3 January. CEO Peter Arduini laid out his plans for the standalone medtech giant at the company’s recent Investor Day 2022.
Philips Admits New Issues In Reworked Ventilators
A silicone foam that replaced hazardous polyurethane in some reworked Philips Trilogy ventilators could separate from the unit and block air flow; additionally, particles have been found in ventilator air pathways.
JPM 2022: Abbott, iRhythm, Novocure, Zimmer Biomet
The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022 as they continue to cope with the impact of the Omicron surge. Here are some of the highlights from the presentations on the second day of the meeting.